Gataca is a brand that specializes in bioinformatics, offering a cutting-edge software pipeline designed specifically for virologists. Powered by deep machine learning, Gataca's flagship product, GAT/ML, merges natural language models, bioinformatics algorithms, and high-performance dataflow systems to revolutionize genomics. GAT/ML goes beyond traditional variant detection, as it is designed to discover emerging variants in real-time, providing predictive insights into evolving quasispecies and shedding light on unseen pathogenic trajectories.

Initially developed for Hepatitis and HIV analytics, GAT/ML can be applied to any disease or sample with sequence heterogeneity, making it incredibly versatile. The software excels at identifying and analyzing mixed populations, using an alignment-free, reference-free system that has the potential to transform research and healthcare. By combining deep learning and genomic complexity, GAT/ML offers a new approach to understanding viral populations and diseases.

In addition to their primary software solution, Gataca also offers custom designed analysis tools, editing/writing services, and study design consultation. With extensive testing and validations, Gataca's solutions are reliable and backed by scientific expertise